HealthcareServices

Personalized Medicine Bioinformatics Market 2026–2030: Forecasting Business Opportunities Ahead

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the personalized medicine bioinformatics market from 2026–2035 with trusted insights from The Business Research Company

How is the Personalized Medicine Bioinformatics Market size predicted to change over the forecast window of 2026–2035?

The personalized medicine bioinformatics market size has experienced rapid expansion in recent years. This market is projected to expand from $3.87 billion in 2025 to $4.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.6%. The historical growth can be linked to factors such as the increased adoption of next-generation sequencing, the expanding accessibility of genomic datasets, heightened research investment in precision medicine, a growing need for data-driven clinical insights, and advancements in bioinformatics algorithms.

The personalized medicine bioinformatics market is anticipated to experience swift expansion in the upcoming period, with projections indicating it will reach a valuation of $7.23 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.3%. This projected growth over the forecast duration stems from factors such as the heightened integration of bioinformatics into clinical processes, increasing financial commitments to personalized medicine initiatives, the broadening of AI-driven clinical decision support systems, the expanding acceptance of population-level genomics analysis, and the surging need for interoperable health data solutions. Key trends anticipated during this forecast timeframe encompass the increasing embrace of AI-powered genomic data analytics, the growing utilization of multi-omics data integration platforms, a rising call for cloud-based bioinformatics services, the wider deployment of pharmacogenomic decision support instruments, and a stronger emphasis on scalable data interpretation frameworks.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28294&type=smp

Which Drivers Are Contributing To The Expansion Of The Personalized Medicine Bioinformatics Market?

The increasing demand for personalized medicine is anticipated to propel the future growth of the personalized medicine bioinformatics market. This medical approach customizes prevention, diagnosis, and therapy according to an individual’s specific genetic makeup, health condition, and lifestyle factors. Personalized medicine is expanding due to advancements in genomic and data analytics, enabling accurate genetic profiling that allows for more precise treatments with improved outcomes and reduced trial-and-error. Personalized medicine bioinformatics analyzes genomic and clinical data to reveal insights into individual health conditions, aiding in accurate treatment choices and drug response predictions while guiding targeted therapies to enhance tailored patient care. For instance, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. Consequently, the growing demand for personalized medicine is driving the expansion of the personalized medicine bioinformatics market.

What Segment Categories Are Covered In The Personalized Medicine Bioinformatics Market?

The personalized medicine bioinformatics market covered in this report is segmented –

1) By Technology: Gene Sequencing, Pharmacogenomics, Microarray Technology, Artificial Intelligence-Driven Analytics Platforms, Other Technologies

2) By Application: Genomics, Proteomics, Transcriptomics, Metabolomics, Epigenomics, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Diagnostics Laboratories, Hospitals And Academic Medical Centers, Contact Research Organizations and Biobanks, Other End-Users

Subsegments:

1) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Single-Molecule Real-Time Sequencing (SMRT), Whole Exome Sequencing (WES), Whole Genome Sequencing (WGS)

2) By Pharmacogenomics: Drug-Gene Interaction Analysis, Adverse Drug Reaction (ADR) Prediction, Biomarker Discovery, Personalized Drug Response Profiling

3) By Microarray Technology: DNA Microarray, RNA Microarray, Protein Microarray, Comparative Genomic Hybridization (CGH) Microarray

4) By Artificial Intelligence-Driven Analytics Platforms: Machine Learning-Based Platforms, Deep Learning-Based Platforms, Natural Language Processing (NLP) Platforms, Predictive Analytics Platforms, Clinical Decision Support Systems (CDSS)

5) By Other Technologies: Proteomics Analysis, Metabolomics Analysis, Epigenomics Profiling, Bioinformatics Cloud Platforms

Which Competitive Trends Are Impacting The Structure Of The Personalized Medicine Bioinformatics Market?

Leading companies active in the personalized medicine bioinformatics market are prioritizing the development of advanced solutions, such as predictive analytics platforms, to enhance the accuracy of disease prediction and improve patient outcomes. A predictive analytics platform leverages machine learning, algorithms, and statistical models to analyze both historical and real-time data for forecasting potential outcomes, thereby enabling healthcare providers to anticipate risks, refine treatment approaches, and make proactive decisions. For example, in April 2023, Certis Oncology Solutions, a US-based biotechnology firm, launched CertisAI, a specialized predictive analytics platform. This AI/ML-driven platform utilizes big data, statistical algorithms, and machine learning to forecast drug efficacy based on gene expression biomarkers, with the aim of accelerating drug discovery and the development of companion diagnostics in precision oncology. The platform is currently validating its unique methodology for predicting therapeutic response and establishing its availability as a service to biopharmaceutical companies to support improved early drug development decisions and personalized cancer treatment strategies.

Which Major Firms Are Strengthening Their Position In The Personalized Medicine Bioinformatics Market?

Major companies operating in the personalized medicine bioinformatics market are F. Hoffmann-La Roche AG, Merck KGaA Darmstadt Germany, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Guardant Health Inc., Sophia Genetics SA, DNAnexus Inc., Deep Genomics Inc., Congenica Ltd, Phase Genomics Inc., Analome Inc., Pluto Bioinformatics Inc., BioBam Bioinformatics S.L., OncoBox Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/personalized-medicine-bioinformatics-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Personalized Medicine Bioinformatics Market?

North America was the largest region in the personalized medicine bioinformatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized medicine bioinformatics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Personalized Medicine Bioinformatics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28294&type=smp

Browse Through More Reports Similar to the Global Personalized Medicine Bioinformatics Market 2026, By The Business Research Company

Genomics Personalized Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Personalized Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Bioinformatics Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioinformatics-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795